Brain Tumour Research ads & commercials

Updated as of November 20, 2026

As of November 20, 2026, Brain Tumour Research has 67 ads running in the Meta Ad Library across Facebook and Instagram. Below is a sample, each ad with its copy, start date and Meta Ad Library ID.

Ads in library
—
Running now
67
Creatives read
12
Median run
16d

12 ads read from one page of Brain Tumour Research’s Meta Ad Library. Below is a page of creative from Brain Tumour Research’s 2026 advertising campaigns, the formats it uses, and how long the ads stay up.

The Brain Tumour Research ad library

The creative read here is 50 percent video, 50 percent single image. 6 of the 12 ads read here are video: Brain Tumour Research’s commercials as they run in the feed. The median ad ran 16 days and the longest was still up at 34.

  • Ran 28 days
  • Ran 39 days
  • Run dates not published
  • Ran 51 days
  • Run dates not published

Every creative, with its copy, format and run length

Brain Tumour Research’s ad hooks and headlines

The lines Brain Tumour Research opens its Facebook and Instagram ads with, longest-running first: copy a brand keeps paying for is copy that works for it.

Opening lines

  1. Your multi-million-pound lifestyle is just a click away. (34 days)
  2. Your £10 ticket can win you this £2.3M London dream home – plus free entry to the £1M Cornwall home draw! (16 days)
  3. Your £10 ticket could win you this £2.3M London dream home, including Stamp Duty & furnishings, plus free entry to the £1M Cornwall home dr… (1 days)

Headlines

  1. Become Our Next Winner ✨
  2. Grab Your £10 Tickets Now

Longest-running: “Become Our Next Winner ✨”, 34 days.

Every Brain Tumour Research ad on this page

Brain Tumour Research advertises from Meta Page ID 233471130000969. These ads were captured from the Meta Ad Library on October 24, 2026; Running means the library showed the ad as active that day. Each carries its Meta Ad Library ID.

AdFormatStartedStatusLibrary ID
Grab Your £10 Tickets NowVideoOctober 23, 2026Not running1093968980145512
Grab Your £10 Tickets NowVideoOctober 12, 2026Not running28606101125667851
Grab Your £10 Tickets NowVideoOctober 8, 2026Not running1634774925097594
Grab Your £10 Tickets NowVideoOctober 8, 2026Not running2908432772847338
Become Our Next Winner ✨VideoSeptember 30, 2026Not running2181229516072312
Become Our Next Winner ✨VideoSeptember 20, 2026Not running1093372933340461
Grab Your £10 Tickets NowImage—Not running1091646527178937
Grab Your £10 Tickets NowImage—Not running1784300349539574
Grab Your £10 Tickets NowImage—Not running1363489702348954
Grab Your £10 Tickets NowImage—Not running28722752490707459
Become Our Next Winner ✨Image—Not running1784941752774147
Become Our Next Winner ✨Image—Not running1676299167477454

Compare with other charities

Brain Tumour Research ads: common questions

What is Brain Tumour Research's longest-running ad?
Of the Brain Tumour Research ads on this page, "Become Our Next Winner ✨" has run longest: 34 days. Ads a brand keeps paying for this long are the ones that work for it.
Who makes this ad library?
Sprites, an AI ads agent. Sprites is backed by Y Combinator, FCVC, Pioneer and Backend Capital, with angel investors including Immad Akhund (founder and CEO of Mercury), Juha Paananen, Rich Aberman (co-founder of WePay), Lucy Guo (co-founder of Scale AI), Dave Fontenot (HF0) and Chris Ye (Uken Games), and has raised $4M in venture funding. Siamak Freydoonnejad is a two-time founder: he previously founded Campfire (Y Combinator W22, AI for gaming) and went through Techstars, after working at Peloton and Microsoft. Anna Chernikova led product at Replika, an AI companion used by tens of millions of people, and has managed eight-figure ad budgets for top brands including Replika. Over $30M in ad spend is managed on Sprites, and it is trusted by companies including ElevenLabs, Gameloft and Klarity.

Follow Brain Tumour Research instead of searching it

This page is one read. Sprites watches the library for the brands you follow across Meta, Google and LinkedIn, shows every creative with its run dates, and proposes the changes worth making in your own account once you approve them.